Exelon Stock (NASDAQ:EXC), Trade Ideas

Exelon

Exelon serves approximately 10 million power and gas customers at its six regulated utilities in Illinois, Pennsylvania, Maryland, New Jersey, Delaware, and Washington, D.C.

News

Small Cap

Markets

ETFs

BWXT

Nuveen Arizona Dividend Advantage Municipal Funds 3

UUUU

The global shift towards clean energy sources has intensified the search for reliable and scalable alternatives to fossil fuels. While the solar and wind power sectors have captured significant attention, a renewed interest in nuclear energy is emerging.

Why These Nuclear Stocks Could Beat Solar and Wind Energy Stocks

Earnings

Penny Stocks

Eurozone

Commodities

Global

Intraday Update

Trading Ideas

MOTS

PANW

THRM

UCAR

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 0.5% on Wednesday.

The Dow traded down 0.16% to 38,503.94 while the NASDAQ fell 0.47% to 15,557.94. The S&amp;P 500 also fell, dropping, 0.11% to 4,969.94.

Crude Oil Moves Higher; Exelon Earnings Top Estimates

Equities

Guidance

Dividends

Exelon Corp reported 15% YoY growth in Q4 earnings, beating estimates. Adjusted EPS improved to $0.60 and quarterly dividend increased by 5.6%.

Exelon Q4 Highlights: Earnings Exceed Projections, Dividend Hike &amp; More

Exelon Corp

Excel Corp

EXCO RESOURCES PAR $ by EXCO Resources, Inc.

EXCO Resources Inc

EXCHANGE BNCSHS INC GA by Exchange Bankshares, Inc.

Exchange Bancshares Inc

Excellerant Inc

Exco Technologies Ltd

Scotiabank analyst Andrew Weisel maintains Exelon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXC#NASDAQ">EXC</a>) with a Sector Perform and lowers the price target from $39 to $37.

Price Target

Analyst Ratings

Scotiabank Maintains Sector Perform on Exelon, Lowers Price Target to $37

The global shift towards clean energy sources has intensified the search for reliable and scalable alternatives to fossil fuels. While the solar and wind power sectors&nbsp;have captured significant attention, a renewed interest in nuclear energy is emerging. Nuclear power, with its potential for consistent baseload generation, small footprint (particularly with newer technologies), and improving safety profile, holds the potential to outperform traditional renewables in specific contexts.
Could nuclear energy stocks be the key to outperforming the broader renewable energy market in the long run?&nbsp;
<h2>Unleashing the Power of the Atom: Uranium Miners</h2>
Uranium, the foundational element of nuclear power, will become an increasingly valuable commodity in the coming years. If the push for clean energy fuels a nuclear resurgence, uranium mining companies will be positioned at the forefront of this transition. Let&#39;s look at some of the key players in this subsector of the mining sector:
<h3>Cameco Corporation&nbsp;</h3>
Cameco Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ccj#NYSE">CCJ</a>), a global giant in uranium production, stands out for its extensive reserves and established track record in the industry. Ranked among the world&#39;s leading uranium producers, Cameco&#39;s expertise and substantial reserves in Canada make it a significant player in the global uranium market.
<h3>Denison Mines</h3>
Denison Mines&nbsp;(AMEX:DNN)&nbsp;is committed to environmentally conscious mining operations. The company is actively involved in exploration and development projects within the Athabasca Basin region of Canada, which is renowned for its abundance of uranium resources. Denison prioritizes environmentally responsible mining practices and holds a diverse portfolio of projects, including exploration and development assets in this uranium-rich region of Canada.
<h3>Energy Fuels</h3>
Energy Fuels (AMEX:UUUU), a US-based mining company, has diversified operations that encompass uranium, vanadium, and rare earth element recovery. This multifaceted approach positions Energy Fuels to capitalize on various critical material needs. Notably, beyond uranium, Energy Fuels engages in the recovery of vanadium and rare earth elements. This unique combination makes them an intriguing player as demand for these materials evolves.
<h3>NexGen Energy</h3>
NexGen Energy&#39;s (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nxe#NYSE">NXE</a>) claim to fame is the high-grade Arrow Deposit, a substantial uranium resource located in Canada&#39;s Athabasca Basin. The quality of this deposit and its projected long mine life make NexGen a company to watch. Additionally, NexGen boasts a relatively low expected production cost, which could improve its profitability if uranium prices surge. The company is also exploring the possibility of using innovative in-situ recovery (ISR) mining techniques, further differentiating its approach.
Uranium miners face unique risks, such as fluctuating commodity prices and the potential for regulatory changes that could impact their operations. However, if the anticipated surge in nuclear power demand materializes, these companies could potentially deliver substantial returns for investors.
<h2>The Next Generation: Reactor Developers</h2>
While traditional nuclear power plants have proven their capabilities, they often come with large capital costs, lengthy construction timelines, and a degree of public anxiety. A wave of innovative companies are tackling these challenges by developing new reactor technologies that promise greater safety, scalability, and potential cost advantages. Let&#39;s examine a few key players in this space:
<h3>NuScale Power&nbsp;</h3>
NuScale Power (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/smr#NYSE">SMR</a>) pioneered small modular reactor (SMR) technology. Unlike traditional plants, SMRs are designed to be smaller, factory-built units that can be deployed more quickly and potentially with lower upfront costs. NuScale aims to make nuclear power more accessible for a broader range of electricity needs, potentially opening new markets for nuclear energy.
<h3>Centrus Energy&nbsp;</h3>
Centrus Energy&nbsp;(AMEX:LEU) isn&#39;t solely focused on reactor design but plays a crucial role in the nuclear fuel cycle. The company is developing advanced nuclear fuels explicitly designed for next-generation reactors. They&#39;ve also forged a significant partnership with TerraPower, a venture-backed by Bill Gates, to advance new reactor technologies. This partnership highlights Centrus&#39; importance in the broader scheme of nuclear innovation.
<h3>BWX Technologies&nbsp;</h3>
BWX Technologies (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bwxt#NYSE">BWXT</a>) has a strong legacy of providing components and services for the existing nuclear power industry. However, it is also looking ahead by actively developing microreactors. These ultra-small reactors hold the potential to provide energy in remote areas or to power specific applications like military bases. BWX&#39;s diversification across both current and future nuclear needs makes it a compelling company to add to your watchlist.
With their advancements, reactor developers have the potential to transform the nuclear power technology landscape. As they strive to make nuclear energy safer, more adaptable to diverse energy demands and scalable, these companies spearhead innovation. Although technological challenges remain, the triumphs of these pioneers could significantly expand nuclear energy&#39;s role in a future powered by clean energy.
<h2>Established Utilities with a Nuclear Advantage</h2>
Traditional energy utilities already heavily invested in nuclear power offer investors a unique way to participate in the sector. While new technologies are exciting, established utility companies with operational nuclear fleets provide exposure to a more established segment of the industry. Let&#39;s take a closer look at two major players:
<h3>Duke Energy&nbsp;</h3>
Duke Energy (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/duk#NYSE">DUK</a>) is a leading US utility company that boasts a substantial nuclear power fleet. This nuclear component complements its diverse portfolio, which also includes renewable energy sources and natural gas generation. For investors, Duke Energy offers a balance between the potential upside of the nuclear sector and the stability of a large, diversified utility company.
<h3>Exelon Corporation&nbsp;</h3>
Exelon Corporation&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/exc#NASDAQ">EXC</a>) holds a dominant position as one of the largest operators of nuclear power plants in the United States. Unlike Duke, Exelon&#39;s power generation relies more heavily on nuclear facilities. This makes Exelon a more direct play on potential legislative or market changes that favor the nuclear energy industry and could lead to increased profitability for the company&#39;s nuclear segment.
Established utilities with significant nuclear operations provide a different investment opportunity than pure-play uranium miners or cutting-edge reactor developers. These utilities offer a way to benefit from a potential nuclear resurgence while also often maintaining a broader portfolio of energy assets that can provide some measure of stability. Investors will need to assess their risk tolerance and the role they envision nuclear stocks playing within their overall portfolio when considering companies like Duke Energy and Exelon.
<h2>Diversifying Nuclear Investment: The Role of ETFs</h2>
Exchange-traded funds (ETFs) provide investors a streamlined way to gain exposure to the nuclear energy sector without directly investing in individual companies. This basket approach can mitigate some risks associated with single stocks while allowing investors to benefit from the sector&#39;s potential growth. Here&#39;s a breakdown of two prominent ETFs in the nuclear space:
<h3>Global X Uranium ETF&nbsp;</h3>
The Global X Uranium ETF (ARCA:URA) is specifically designed to track companies involved in the mining and producing of uranium, along with businesses engaged in related stages of the nuclear fuel cycle. This ETF offers investors a more targeted way to bet on the rising demand for uranium if the resurgence of nuclear power comes to fruition.
<h3>VanEck Uranium+Nuclear Energy ETF</h3>
The VanEck Uranium+Nuclear Energy ETF (ARCA:NLR) adopts a slightly broader approach than the Global X Uranium ETF. While still capturing exposure to uranium-related companies, this ETF also includes companies engaged in constructing and operating nuclear power plants. This expanded focus could benefit if both uranium demand and positive sentiment towards atomic power generation increase in tandem.
Nuclear energy ETFs present an appealing option for investors seeking a convenient and diversified approach to the industry. These ETFs eliminate the need for extensive research into individual companies but still give investors access to the potential growth trajectory of the nuclear sector. Investors must carefully consider the specific holdings and management fees of any exchange-traded fund before investing.
<h2>Policy and Regulation: The X-Factor</h2>
Government policies and regulations are pivotal in shaping the nuclear energy landscape. Favorable policies, like tax incentives or streamlined development processes, could ignite the sector, while restrictive regulations could hamper its growth. Investors need to keep a close eye on the evolving regulatory environment, as policies can greatly influence the prospects for nuclear-related investments.
<h2>Nuclear Power in A Global Context</h2>
Developing economies with booming energy needs could turn to nuclear power as a solution to reduce reliance on fossil fuels and address growing energy security concerns. China and India, for instance, already have ambitious nuclear power expansion plans. This global trend underscores the long-term potential for the nuclear sector and its associated stocks.
<h2>Challenges and Considerations: The Other Side of the Equation</h2>
Acknowledging the challenges and potential risks associated with nuclear power before making any investment decisions is essential. These include:
<ul>
<li>Waste Disposal: The safe and long-term storage of radioactive waste remains a contentious issue. While technological advancements offer potential solutions, this remains a concern for investors and the communities surrounding nuclear plants.</li>
<li>Risk of Accidents: Though safety standards have significantly improved, the potential for accidents, however rare, can generate public fear and negatively impact nuclear investments.</li>
<li>Long Development Timelines: Constructing new nuclear power plants can be lengthy and capital-intensive, making investment returns less immediate than other energy sectors.</li>
</ul>
Nuclear energy stocks have the potential to be lucrative investments in the long term, particularly if the growing need for reliable, low-carbon energy outweighs the industry&#39;s concerns and challenges. Nuclear technology isn&#39;t a silver bullet, but it can play a significant role in the diverse energy mix required for a sustainable future. While nuclear may not fully eclipse solar and wind power, the unique advantages of atomic energy may prove essential on the path toward a cleaner energy future.
The article &quot;<a href="https://www.marketbeat.com/stock-ideas/why-these-nuclear-stocks-could-beat-solar-and-wind-energy-stocks/">Why These Nuclear Stocks Could Beat Solar and Wind Energy Stocks</a>&quot; first appeared on MarketBeat.

Exelon's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXC#NYSE">EXC</a>) short percent of float has risen 25.6% since its last report. The company recently reported that it has 15.68 million shares sold short, which is 1.57% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.41 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Exelon Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1711472430_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Exelon has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Exelon's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Exelon's peer group average for short interest as a percentage of float is 2.72%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

(EXC) - Analyzing Exelon's Short Interest

Barclays analyst Nicholas Campanella maintains Exelon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXC#NASDAQ">EXC</a>) with a Overweight and raises the price target from $36 to $39.

Barclays Maintains Overweight on Exelon, Raises Price Target to $39

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 0.5% on Wednesday.
The Dow traded down 0.16% to 38,503.94 while the NASDAQ fell 0.47% to 15,557.94. The S&amp;P 500 also fell, dropping, 0.11% to 4,969.94.
Check This Out: <a href="https://www.benzinga.com/news/24/02/37210537/top-4-tech-stocks-that-may-crash-this-month"> Top 4 Tech Stocks That May Crash This Month</a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Energy shares rose by 1.5% on Wednesday.
In trading on Wednesday, information technology shares fell by 1%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
Exelon Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/exc#NASDAQ">EXC</a>) reported better-than-expected fourth-quarter financial results and increased its quarterly dividend.
Exelon reported fourth-quarter fiscal 2023 operating revenue growth of 15% year-over-year to $5.37 billion, beating the estimates of $4.17 billion. Adjusted EPS improved to 60 cents from 43 cents in 2022, beating the estimate of 58 cents.
&nbsp;
<h3>Equities Trading UP</h3>
&nbsp;
MediaAlpha, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/max#NYSE">MAX</a>) shares shot up 18% to $18.71 after the company reported better-than-expected fourth-quarter financial results.
Shares of Gentherm Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/thrm#NASDAQ">THRM</a>) got a boost, surging 23% to $60.65 after the company reported better-than-expected fourth-quarter financial results and issued guidance.
Motus GI Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mots#NASDAQ">MOTS</a>) shares were also up, gaining 58% to $1.0326 after the company was granted U.S. Patent #11904085 for &#39;Systems And Methods For Cleaning A Colon.&#39;
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
Palo Alto Networks, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/panw#NASDAQ">PANW</a>) shares dropped 27% to $268.49 after the company issued third-quarter adjusted EPS and total revenue guidance below estimates.
Shares of U Power Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ucar#NASDAQ">UCAR</a>) were down 30% to $0.0716 after the company received a delisting notice from the Nasdaq Stock Market due to its ordinary shares&rsquo; closing bid price falling below $0.10 for ten consecutive trading days, as per the Low Priced Stocks Rule.
Community Health Systems, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cyh#NYSE">CYH</a>) was down, falling 26% to $2.97 after the company reported fourth-quarter financial results.
Also Check This Out:<a href="https://www.benzinga.com/news/24/02/37210908/alaska-air-to-rally-around-36-here-are-10-top-analyst-forecasts-for-tuesday"> Alaska Air To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Tuesday</a>
&nbsp;
<h3>Commodities</h3>
&nbsp;
In commodity news, oil traded up 0.6% to $77.52 while gold traded down 0.3% at $2,034.40.
Silver traded down 1.1% to $22.88 on Wednesday while copper rose 0.1% to $3.8730.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares were mostly higher today. The eurozone&rsquo;s STOXX 600 fell 0.22%, London&rsquo;s FTSE 100 fell 0.75% while Spain&rsquo;s IBEX 35 Index rose 0.67% The German DAX gained 0.22% French CAC 40 rose 0.17% while Italy&rsquo;s FTSE MIB Index rose 1%.
The Confederation of British Industry survey&#39;s total order book balance climbed by 10 points to a reading of -20 in February.
&nbsp;
<h3>Asia Pacific Markets</h3>
&nbsp;
Asian markets closed mixed on Wednesday, with Japan&rsquo;s Nikkei 225 falling 0.26%, Hong Kong&rsquo;s Hang Seng Index rising 1.57%, China&rsquo;s Shanghai Composite Index gaining 0.97% and India&rsquo;s S&amp;P BSE Sensex falling 0.59%.
Japanese trade deficit narrowed to JPY 1,758.311 billion in January from JPY 3,506.43 billion in the year-ago month. Exports from Japan surged by 11.9% year-over-year, while imports to Japan dipped 9.6% year-over-year.
&nbsp;
<h3>Economics</h3>
&nbsp;
U.S. mortgage applications fell by 10.6% on the week ending Feb. 16, 2024.
Now Read This: <a href="https://www.benzinga.com/news/24/02/37209778/starbucks-regeneron-pharmaceuticals-and-2-other-stocks-insiders-are-selling"> Starbucks, Regeneron Pharmaceuticals And 2 Other Stocks Insiders Are Selling</a>

Exelon Corp&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXC#NASDAQ">EXC</a>) reported fourth-quarter fiscal 2023 operating revenue growth of 15% year-over-year to $5.37 billion,&nbsp;<a target="_blank" href="https://www.benzinga.com//node/37232355" rel="noreferrer noopener">beating the estimates of $4.17 billion.</a>
Adjusted EPS improved to $0.60 from $0.43 in 2022, beating the estimate of $0.58.
ComEd&#8217;s Adjusted Operating Earnings increased to $269 million from $211 million YoY, primarily due to increases in electric distribution formula rate earnings.
PECO&#8217;s Adjusted Operating Earnings increased to $154 million from $102 million YoY, primarily due to distribution rate increases and favorable impacts from lower storm costs.
BGE&#8217;s Adjusted Operating Earnings increased to $199 million from $114 million YoY, primarily due to favorable impacts of the multi-year plans, including the recognition of the reconciliation in 2023.
PHI&#8217;s Adjusted Operating Earnings increased to $102 million from $90 million YoY due to distribution and transmission rate increases and timing of excess deferred tax amortization.
Exelon&#8217;s net cash flows generated by operating activities for the fiscal 2023 totaled $4.70 billion, compared to $4.87 billion in 2022.
The company&#8217;s cash, restricted cash, and cash equivalents at the end of the quarter totaled $1.10 billion.
Dividend:&nbsp;EXC declared a quarterly dividend of $0.38 per share for the first quarter of 2024, representing a 5.6% growth over last quarter&#8217;s dividend. The dividend is payable on March 15, 2024, to shareholders of record as of 5 p.m. Eastern time on March 4, 2024.
&#8220;Over the next four years, Exelon will invest $35 billion to serve our customers, resulting in 7.5% rate base growth and an expected annualized earnings growth rate of 5% to 7% through 2027, off the midpoint of our 2023 guidance, with an expectation of being at midpoint or better in that range,&#8221; commented Exelon Chief Financial Officer Jeanne Jones.
2024 Outlook:&nbsp;EXC expects adjusted EPS of $2.40 to $2.50 versus $2.41 consensus, driven by continued investment in jurisdictions&#8217; energy transformations and doing so as affordably and efficiently as possible.
&#8220;In 2024, we will continue to innovate and partner with regulators and stakeholders across Exelon&#8217;s jurisdictions to support our shared energy and environmental goals, while demonstrating the power of impact for our customers and communities&#8221;, commented President and CEO Calvin Butler.
Price Action:&nbsp;EXC shares are trading higher by 4% at $36.12 on the last check Wednesday.

Exelon Q4 Highlights: Earnings Exceed Projections, Dividend Hike & More

WIIM

Exelon shares are trading higher after the company reported better-than-expected Q4 financial results and issued FY24 adjusted operating EPS guidance. Also, the company increased its quarterly dividend.

U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Wednesday.
Shares of Toll Brothers, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tol#NYSE">TOL</a>) gained during Wednesday&rsquo;s session after the company reported better-than-expected first-quarter financial results and <a href="https://www.benzinga.com/news/earnings/24/02/37234324/why-is-toll-brothers-stock-trading-higher-wednesday">issued FY24 EPS guidance above estimates</a>.
The company reported first-quarter 2024 earnings per share of $2.25, beating the analyst consensus of $1.78. Quarterly revenues of $1.948 billion beat the street view of $1.859 billion.
Toll Brothers shares rose 6.2% to $109.93 on Wednesday.
Here are some other big stocks recording gains in today&rsquo;s session.
<ul>
<li>Gentherm Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/thrm#NASDAQ">THRM</a>) shares jumped 24.7% to $61.48 after the company reported better-than-expected fourth-quarter financial results and issued guidance.</li>
<li>MediaAlpha, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/max#NYSE">MAX</a>) rose 19% to $18.80 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>Janux Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/janx#NASDAQ">JANX</a>) gained 18% to $11.75. Janux Therapeutics will host virtual event on Feb. 26th, 2024, at 4:30PM ET to discuss updated clinical data for PSMA-TRACTr JANX007 and EGFR-TRACTr JANX008.</li>
<li>Iovance Biotherapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iova#NASDAQ">IOVA</a>) rose 15.9% to $13.95.</li>
<li>TPG RE Finance Trust, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/trtx#NYSE">TRTX</a>) jumped 12.9% to $6.24 after the company reported fourth-quarter financial results.</li>
<li>Garmin Ltd.(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/grmn#NYSE">GRMN</a>) rose 12.2% to $137.72 after the company reported fourth-quarter financial results and issued FY24 revenue guidance above estimates, recommended boosting annual dividend and authorized share buyback.</li>
<li>Select Water Solutions, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wttr#NYSE">WTTR</a>) gained 11.7% to $8.77 following strong earnings.</li>
<li>The Hackett Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hckt#NASDAQ">HCKT</a>) surged 11.2% to $25.48 following upbeat results.</li>
<li>Comstock Resources, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/crk#NYSE">CRK</a>) gained 10.7% to $8.35.</li>
<li>Antero Resources Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ar#NYSE">AR</a>) rose 10.5% to $25.89.</li>
<li>LivaNova PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/livn#NASDAQ">LIVN</a>) jumped 8.8% to $57.28 following upbeat earnings.</li>
<li>EQT Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eqt#NYSE">EQT</a>) gained 8.8% to $36.69.</li>
<li>Wix.com Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wix#NASDAQ">WIX</a>) gained 8.6% to $136.15 following fourth-quarter results.</li>
<li>Bausch + Lomb Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/blco#NYSE">BLCO</a>) gained 8.6% to $15.84 after reporting quarterly results.</li>
<li>NeoGenomics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/neo#NASDAQ">NEO</a>) rose 7.4% to $15.78 after the company reported better-than-expected fourth-quarter financial results and issued FY24 adjusted EPS guidance above estimates.</li>
<li>Constellium SE (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cstm#NYSE">CSTM</a>) gained 6.7% to $19.83 following quarterly results.</li>
<li>Exelon Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/exc#NASDAQ">EXC</a>) rose 3.9% to $36.07 following strong results.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/02/37237721/bitcoin-falls-below-51-000-starknet-becomes-top-loser"> Bitcoin Falls Below $51,000; Starknet Becomes Top Loser </a>

Movers

BLCO

CSTM

GRMN

HCKT

IOVA

JANX

LIVN

TRTX

WTTR

Toll Brothers Posts Upbeat Earnings, Joins Exelon, Garmin, Bausch + Lomb And Other Big Stocks Moving Higher On Wednesday

<div>The dividend is payable on Friday, March 15, 2024, to shareholders of record of Exelon as of 5 p.m. Eastern time on Monday, March 4, 2024.</div>

Exelon Boosts Quarterly Dividend By 5.6% From $0.36 To $0.38 Per Share

Exelon Introduces 2024 Adjusted Operating EPS Guidance Range Of $2.40-$2.50, Est $2.41

Exelon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXC#NASDAQ">EXC</a>) reported quarterly Adj earnings of $0.60 per share which beat the analyst consensus estimate of $0.58 by 3.45 percent. This is a 39.53 percent increase over earnings of $0.43 per share from the same period last year. The company reported quarterly sales of $5.37 billion which beat the analyst consensus estimate of $4.17 billion by 28.64 percent. This is a 15.02 percent increase over sales of $4.67 billion the same period last year.

Exelon Q4 Adj EPS $0.60 Beats $0.58 Estimate, Sales $5.37B Beat $4.17B Estimate

ACVA

ALIT

AMSF

ANSS

ATNI

BALY

BELFA

BELFB

BRDG

BROS

BRSP

CAKE

CCAP

CCRN

CCSI

CENX

CHDN

CHRD

CNNE

COKE

CSTE

DINO

DOCN

ECPG

ERII

ESEA

ETSY

EXAS

FIVN

GATO

GKOS

GLBE

GOOD

GSHD

ICLR

INSG

IONS

JACK

JOBY

KALU

LANV

LCID

LUNG

MATV

MGRC

MTLS

NDSN

NEXA

NGVT

NOVA

NVDA

NVRO

NYMT

OBDC

Earnings Scheduled For February 21, 2024

With U.S. stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
Wall Street expects NVIDIA Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvda#NASDAQ">NVDA</a>) to report quarterly earnings at $4.64 per share on revenue of $20.62 billion after the closing bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. NVIDIA shares fell 1.9% to $681.03 in after-hours trading.
La-Z-Boy Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lzb#NYSE">LZB</a>) reported downbeat results for its third quarter. La-Z-Boy shares dipped 8.6% to $34.50 in the after-hours trading session.
Analysts are expecting Analog Devices, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adi#NASDAQ">ADI</a>) to earn $1.71 per share on revenue of $2.50 billion for the latest quarter. The company will release earnings before the markets open. Analog Devices shares rose 0.3% to $189.87 in after-hours trading.
Check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a> 
Keysight Technologies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/keys#NYSE">KEYS</a>) reported upbeat earnings for its first quarter but issued weak guidance for the second quarter. The company said it sees second-quarter earnings of $1.34 to $1.40 per share on revenue of $1.19 billion to $1.21 billion. Keysight shares fell 6.8% to $144.00 in the after-hours trading session.
Analysts expect Exelon Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/exc#NASDAQ">EXC</a>) to report quarterly earnings at 58 cents per share on revenue of $4.17 billion before the opening bell, according to Benzinga Pro. Exelon shares gained 1.5% to $35.25 in after-hours trading.
Check This Out: <a href="https://www.benzinga.com/news/24/02/37210537/top-4-tech-stocks-that-may-crash-this-month"> Top 4 Tech Stocks That May Crash This Month </a>

Pre-Market Outlook

KEYS

Nvidia, La-Z-Boy And 3 Stocks To Watch Heading Into Wednesday

The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index remained in the &quot;Greed&quot; zone on Tuesday.
U.S. stocks closed lower on Tuesday, with the Nasdaq falling more than 100 points during the session. All three major indices recorded losses last week, ending their five-week winning streaks.
On the economic data front, the Conference Board&#39;s Leading Economic Index fell 0.4% for January versus market expectations for a 0.3% decline.
Capital One Financial Corp (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cof#NYSE">COF</a>) announced its plans to purchase Discover Financial Services (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dfs#NYSE">DFS</a>), marking a pivotal $35.3 billion all-stock transaction. Walmart Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amt#NYSE">AMT</a>) shares gained over 3% on Tuesday after the company reported better-than-expected fourth-quarter financial results.
Most sectors on the S&amp;P 500 closed on a negative note, with consumer discretionary, energy and information technology stocks recording the biggest losses on Tuesday. However, consumer staples stocks bucked the overall market trend, closing the session higher.
The Dow Jones closed lower by around 64 points to 38,563.80 on Tuesday. The S&amp;P 500 fell 0.60% at 4,975.51, while the Nasdaq Composite fell 0.92% at 15,630.78 during Tuesday&rsquo;s session.
Investors are awaiting earnings results from Exelon Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/exc#NASDAQ">EXC</a>), Exelon Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adi#NASDAQ">ADI</a>), Exelon Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvda#NASDAQ">NVDA</a>) and Rivian Automotive, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rivn#NASDAQ">RIVN</a>) today.
At a current reading of 67.3, the index remained in the &quot;Greed&quot; zone on Tuesday, versus a prior reading of 69.2.
What is CNN Business Fear &amp; Greed Index?
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
&nbsp;
Read Next: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/02/37211132/beasley-broadcast-and-2-other-stocks-under-3-insiders-are-buying"> Beasley Broadcast And 2 Other Stocks Under $3 Insiders Are Buying </a>

RIVN

Investor Sentiment Falls Further; Fear & Greed Index In 'Greed' Zone

Exelon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXC#NASDAQ">EXC</a>) is set to give its latest quarterly earnings report on Wednesday, 2024-02-21. Here's what investors need to know before the announcement.
Analysts estimate that Exelon will report an earnings per share (EPS) of $0.58. 
Exelon bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
Last quarter the company missed EPS by $0.01, which was followed by a 0.34% drop in the share price the next day.
Here's a look at Exelon's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.68</td>
<td>0.40</td>
<td>0.66</td>
<td>0.43</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.67</td>
<td>0.41</td>
<td>0.70</td>
<td>0.43</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-0.34%</td>
<td>-2.41%</td>
<td>0.54%</td>
<td>1.52%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1708448456_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Exelon were trading at $34.91 as of February 19. Over the last 52-week period, shares are down 16.4%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/EXC/earnings">To track all earnings releases for Exelon visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Outlook For Exelon

Mike Innocenzo named Exelon Chief Operating Officer. Dave Velazquez to succeed Innocenzo as President and CEO of PECO. Denise Galambos to succeed Amy Best as Exelon Chief Human Resources Officer as Best announces retirement.
Exelon (Nasdaq, EXC) announced today that Mike Innocenzo, currently president and chief executive officer of Exelon subsidiary PECO, has been promoted to executive vice president and chief operating officer of Exelon, reporting to Exelon President and Chief Executive Officer Calvin Butler. Innocenzo will oversee all utility operations and the CEOs of BGE, ComEd, PECO and PHI will report to him. He will also be responsible for the Cyber &amp; Information Security Services, Corporate Physical Security, IT, Safety, Supply, Training and Transmission Strategy &amp; Compliance organizations. Dave Velazquez, currently Exelon executive vice president of Utility Operations and Technology, will succeed Innocenzo as president and chief executive officer of PECO, Pennsylvania's largest electric and natural gas delivery company serving nearly 1.7 million electric customers and more than 548,000 natural gas customers in southeastern Pennsylvania.
"As we focus on leading an equitable energy transformation for our customers and communities, making a positive impact begins with the talent and experience of our team," said Butler. "We are pleased to have Mike Innocenzo, who has spent his career delivering operational excellence at PECO, bring his expertise to overseeing operations across Exelon. Mike will build on the top-tier performance levels our customers have come to expect. Similarly, we have a high caliber, respected industry leader in Dave Velazquez, with experience leading utilities, to continue PECO's advance toward best-in-class service. Both leaders are a testament to the depth of experience at Exelon."
Exelon's Executive Vice President and Chief Human Resources Officer (CHRO) Amy Best has announced she will retire in May. Best has been with the company for 32 years, serving as Exelon's CHRO since 2012. During her tenure, Exelon has been widely recognized for its commitment to DEI, pay equity and family leave policies. Denise Galambos will succeed Best as senior vice president and Exelon's CHRO. Denise currently serves as Baltimore Gas and Electric's (BGE) senior vice president of Customer Operations.
"One of Amy's most notable accomplishments has been designing and nurturing a diverse and inclusive company culture where employees feel valued and safe bringing their authentic selves to work each day," said Butler. "This has been the foundation of Exelon's leading talent attraction and development capabilities. On behalf of our 19,500 employees, our entire executive leadership team thanks Amy for her dedicated service to this company and our people, and we wish her well in her new chapter. We're also excited to welcome Denise Galambos to her new role and look forward to her leadership as we continue to strengthen our culture and power a cleaner and brighter future for our customers and communities."
Innocenzo will assume the chairmanship of the boards of directors at BGE, ComEd, PECO and Pepco Holdings. Velazquez will assume the vice-chairmanship of the board of directors at PECO. Galambos will join Exelon's Executive Committee. Innocenzo, Velazquez and Galambos will transition to their new roles on April 1, 2024.
More about Mike Innocenzo
Innocenzo joined the company in 1988 and has served in a range of roles of increasing responsibility in Electric and Gas Distribution Operations, Energy Management, Smart Grid, Process Improvement, and Project Management. Before assuming the CEO role at PECO in 2018, he served as PECO's chief operating officer. Innocenzo has served as Board Chair of The Greater Philadelphia Chamber of Commerce since 2022. He also serves on the boards of the Philadelphia Police Athletic League (PAL), the Franklin Institute, the American Gas Association, and the Electric Power Research Institute. He is a member of the Satell Institute and has advisory roles with Drexel University and Children's Hospital of Philadelphia. Innocenzo holds a bachelor's degree in electrical engineering from Widener University and an MBA from Villanova University.
More about Dave Velazquez
Velazquez has more than 40 years of utility and energy industry experience. He joined Exelon in 2016 at the merger of Exelon and Pepco Holdings, assuming the role of PHI president and CEO. Prior to the merger, Velazquez was the executive vice president and leader of the power delivery business for Pepco Holdings. He managed over 95 percent of the business and employee base and was responsible for all utility operations in three states and the District of Columbia including IT and support services, and the relationship with four local unions. From 2006 to 2009, Velazquez served as president and CEO of Conectiv Energy, then Pepco Holdings' competitive merchant generation and energy trading subsidiary. He served as vice president of strategic planning and chief risk officer of Pepco Holdings from 2005 to 2006.
Velazquez has served on the boards of several educational and community organizations, such as the Trust for the National Mall, Smithsonian's National Zoo and Conservation Biology Institute Advisory Board, Greater Washington Board of Trade, Federal City Council, D.C. Policy Center of the Federal City Council, Emeritus Advisory Board of the American Association of Blacks in Energy, and United Way of the National Capital Area. He has also served as a board member of Southeastern Electric Exchange, Association of Edison Illuminating Companies, and is a member of the Edison Foundation Institute for Electric Innovation Management Committee. Velazquez is a graduate of Widener University where he earned his bachelor's degree in engineering.
More about Denise Galambos
Galambos has held several leadership roles at Exelon since joining the company in 2012 as part of Constellation and BGE's merger into Exelon. Before moving into the chief customer officer role at BGE, she was vice president of Utility Oversight and was responsible for identifying and developing policy positions which furthered the overall business strategy across multiple operating companies. She ensured coordination on key issues such as non-wires alternatives, distribution planning, decarbonization and electrification strategies. Prior to her policy role, she was vice president of Human Resources where she oversaw Labor Relations including a first contract negotiation, talent management, succession planning, compensation and diversity, equity and inclusion at BGE. Galambos also worked in Exelon's legal department as an associate general counsel for Labor and Employment.
Galambos is active in the Baltimore community, serving on the boards of the Hippodrome Foundation, Baltimore Museum of Art, Baltimore Symphony Orchestra, SquashWise, and Arts for Learning, Maryland. She is a graduate of the University of Wisconsin Law School and received her bachelor's degree from Princeton University.

Management

Exelon Announces Executive Leadership Changes; Mike Innocenzo Named Exelon Chief Operating Officer; Dave Velazquez To Succeed Innocenzo As President And CEO Of PECO

Barclays analyst Eric Beaumont maintains Exelon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXC#NASDAQ">EXC</a>) with a Overweight and lowers the price target from $38 to $36.

Barclays Maintains Overweight on Exelon, Lowers Price Target to $36

B of A Securities analyst Paul Zimbardo maintains Exelon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXC#NASDAQ">EXC</a>) with a Neutral and lowers the price target from $38 to $36.

B of A Securities Maintains Neutral on Exelon, Lowers Price Target to $36

Exelon's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXC#NYSE">EXC</a>) short percent of float has fallen 13.04% since its last report. The company recently reported that it has 9.92 million shares sold short, which is 1.0% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.0 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Exelon Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1704915913_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Exelon has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Exelon's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Exelon's peer group average for short interest as a percentage of float is 2.44%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Mizuho analyst Paul Fremont upgrades Exelon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXC#NASDAQ">EXC</a>) from Neutral to Buy and raises the price target from $36 to $39.

Upgrades

Mizuho Upgrades Exelon to Buy, Raises Price Target to $39

Constellation Energy's Starry Returns (Ratings Downgrade)

Stocks To Power Lines, The Evolution Of Berkshire Hathaway

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Warren Buffett stocks can teach you a thing or two about investing. Warren Buffett&rsquo;s annual shareholders letter to Berkshire Hathaway (NYSE:<a href="https://investorplace.com/stock-quotes/brk-a-stock-quote/">BRK-A</a>)(NYSE:<a href="https://investorplace.com/stock-quotes/brk-b-stock-quote/">BRK-B</a>) investors outlines what he&rsquo;s done the past year and often why. Along the way, he drops pearls of wisdom and golden nuggets of investing truths.



Yet it&rsquo;s not so much what Buffett says but what he does. As a super investor he doesn&rsquo;t have to play by the same rules as you and me. The SEC affords him and other billionaires special privileges they withhold from us. For example, Buffett doesn&rsquo;t always have to divulge his big bets to ensure he gets the best price.



However, Buffett also has a secret stash that not many investors are familiar with. Berkshire Hathaway acquired specialty investment company New England Asset Management (NEAM) when it bought General Re in 1998. It&rsquo;s a &ldquo;secret&rdquo; portfolio with numerous hidden gems, companies that don&rsquo;t always appear in Berkshire Hathaway&rsquo;s portfolio. While Buffett doesn&rsquo;t actively manage the investment portfolio as he does with his primary vehicle, Berkshire still effectively owns its assets.



NEAM recently purchased the following three Warren Buffett stocks, hiding in plain sight.



<h2>Pfizer (PFE)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/08/pfe-stock-3-300x169.jpg" alt="Pfizer logo on Pfizer building. Pfizer is an American pharmaceutical corporation."><div>Source: Manuel Esteban / Shutterstock.com</div></div>It&rsquo;s no secret Buffett likes a bargain and stocks trading at a discount to their intrinsic value. Pharmaceutical giant Pfizer (NYSE:<a href="https://investorplace.com/stock-quotes/pfe-stock-quote/">PFE</a>) fits the bill as its stock trades 32% below where it stood a year ago and regularly tests new lows. PFE stock recently touched a level it hadn&rsquo;t seen in a decade.



The <a href="https://investorplace.com/2023/12/3-stocks-that-just-hit-a-52-week-low-time-to-back-up-the-truck/">loss of revenue</a> from its Covid therapeutics is sinking the company. It generated $52 billion in sales from those shots in 2022 but only $12.7 billion last year. It hopes to see $8 billion worth this year.



What&rsquo;s worse is that the pharma stock has a handful of therapies generating over $1 billion a year in revenue. Yet, almost all have <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000078003/000007800324000017/pfe-20240130.htm">suffered significant sales declines</a> or posted anemic growth. Eliquis and Prevnar, for example, were up 4% and 2%, respectively; Xeljanz and Enbrel were off 5% and 17%, respectively; revenue from oncology treatments Ibrance and Xtandi fell 7% and 1%, respectively.



Although some therapies grew by double-digit rates, the overall effect was a 42% decline in sales in 2023. Yet the stock is cheap. It trades at only 10 times next year&rsquo;s earnings, which are expected to grow by 23%. As it pursues a growth-by-acquisition strategy to bolster its drug pipeline, PFE stock was just too cheap for NEAM to ignore.



<h2>Amgen (AMGN)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/AMGN1600-300x169.jpg" alt=""><div>Source: Shutterstock</div></div>Biotech behemoth Amgen (NASDAQ:<a href="https://investorplace.com/stock-quotes/amgn-stock-quote/">AMGN</a>) has some of the same issues as Pfizer though to a lesser degree. Its growth trajectory last year wasn&rsquo;t all that spectacular once you removed the impact of acquisitions it made. The results disappointed investors. AMGN shares are down 4% this year but 20% higher over the last 12 months.



The biotech&rsquo;s own portfolio of billion-dollar drugs did grow year over year, though not as quickly as some hoped. Yet Amgen has a robust pipeline of therapies that will be key in defending its portfolio from biosimilars even as it pursues it&rsquo;s own development of biosimilar drugs.



Amgen also has a solid presence internationally in its core therapeutic circle of competency. New acquisitions strengthen its ability to identify potential new drug targets. Recently launched branded and biosimilar drugs should allow the biotech to maintain its strong record of returning value to shareholders.&nbsp;



With Amgen stock trading at 13 times next year&rsquo;s earnings and 20 times its free cash flow, NEAM saw this as an opportunity to add to its position.



<h2>Exelon (EXC)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/03/exc-exelon-1600-300x169.png" alt="The logo for Exelon (EXC) is visible at the top of an office building."><div>Source: photosounds / Shutterstock.com</div></div>Electric utility Exelon (NYSE:<a href="https://investorplace.com/stock-quotes/exc-stock-quote/">EXC</a>) is another beaten down stock, though nowhere near Pfizer or Amgen. EXC stock is up 2% in 2024. This is a new addition to the New England Asset Management portfolio though. It purchased 133,650 shares that have a value of $4.8 million, or less than 1% of the portfolio&rsquo;s total. This could be a base on which to build.



The utility provides gas and electricity to 10 million customers on the east coast and plans on spending some $35 billion in capital expenditures over the next four years. It saw revenue in the fourth quarter rise 15% to $5.4 billion as higher utility rates went into effect.&nbsp;



Inflation and higher interest rates pressure Exelon&rsquo;s performance, as they do most capital-intensive businesses. Although the Federal Reserve didn&rsquo;t cut rates at its latest meeting it did indicate rate cuts were coming later this year, which helped lift the utility sector. EXC stock is up more than 10% from its February lows.



Exelon&rsquo;s dividend yields 4% annually and is well supported. The regulated utility offers good growth prospects and stable cash flows for investors.



On the date of publication, Rich Duprey did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com <a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/">Publishing Guidelines</a>.
<div>Rich Duprey has written about stocks and investing for the past 20 years. His articles have appeared on Nasdaq.com, The Motley Fool, and Yahoo! Finance, and he has been referenced by U.S. and international publications, including MarketWatch, Financial Times, Forbes, Fast Company, USA Today, Milwaukee Journal Sentinel, Cheddar News, The Boston Globe, L&rsquo;Express, and numerous other news outlets.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT793992">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/02/wall-street-legend-issues-urgent-ai-code-red/?cid=MKT781156&amp;eid=MKT793990">&ldquo;America&rsquo;s Top Trader&rdquo; Issues A.I. Code Red: Act Now or Miss Out</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793999">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/03/buffetts-backdoor-buys-3-stocks-his-secret-portfolio-is-quietly-accumulating/">Buffett&#8217;s Backdoor Buys: 3 Stocks His Secret Portfolio Is Quietly Accumulating</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Buffett's Backdoor Buys: 3 Stocks His Secret Portfolio Is Quietly Accumulating

Exelon: Rate-Base Scale, Cost Management Drive Upside Potential

IVV: S&P 500 Dashboard For April 2024

Buy 9 Sustainable Dividend Dogs Of Barron's Top 100

Mizuho Securities analyst Anthony Crowdell has maintained their bullish stance on EXC stock, giving a Buy rating on April 1. Anthony Crowdell has g...

Exelon: A Resilient Buy Amid Regulatory Challenges and Growth Prospects

FUTY: Utilities Dashboard For April

In a report released on April 19, Shelby Tucker from RBC Capital maintained a Hold rating on Exelon (EXC – Research Report), with a price target of...

RBC Capital Sticks to Its Hold Rating for Exelon (EXC)

The Sound Shore Fund Q1 2024 Letter To Shareholders

AMGN

BLDR

CHTR

DUKB

FLEX

FUTY

INGR

MDLZ

NXPI

PCAR

RSPU

SOJC

SOJD

SOJE

SREA

TEVA

TEVJF

Press Releases

ComEd Refiles Multi-Year Grid Plan to Advance Region's Economic, Climate and Equity Goals

ComEd Joins Village of University Park, Will County Department of Health, Crete-Monee School District 201U & Other Community Organizations to Bring Support Services Directly to Families in Need

ComEd, HIRE360 Accepting New Applications for Take Charge EV Pre-Apprenticeship Program

ComEd Announces Elmhurst Substation Expansion Project to Power Regional Economic Growth

ComEd Job Training Programs Graduate Nearly 80 Area Residents

ComEd, Chicago Park District Invite Illinois Residents to Enter Sweepstakes to Turn on Iconic Buckingham Fountain

PECO to Voluntarily Delist Capital Trust Receipts from NYSE

Chris Crane, Former CEO of Exelon, Passed Away at 65

Gov. Pritzker Joins ComEd to Present G&W Electric with Record High $2.6 Million Rebate for Largest Commercial Solar/Storage Installation in Illinois

ComEd Joins Bronzeville Community to Unveil New Public EV Chargers

American Electric Power Company, Inc. - Common Stock

American Electric Power

Avangrid

Constellation Energy Corporation - Common Stock

Constellation Energy

Comp En De Mn Cemig ADS American Depositary Shares

Cia Energetica DE Minas

Comp En De Mn Cemig ADS American Depositary Receipts

Duke Energy Corporation (Holding Company) Common Stock

Duke Energy

Centrais Electricas Brasileiras S A American Depositary Shares (Each representing one Common Share)

Centrais Eletricas

Centrais Electricas Brasileiras S.A.- Eletrobr?!s American Depositary Shares (Each representing one Preferred Share)

Edison Intl